kappa-Opioid withdrawal in Planaria.

Opposing roles of voltage-gated Ca2+ channels in neuronal control of regenerative patterning. J Neurosci (2011) 0.94

The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Res (2007) 0.85

Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur J Pharmacol (2007) 0.78

5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians. Neurosci Lett (2010) 0.75

Planarian brain regeneration as a model system for developmental neurotoxicology. Regeneration (Oxf) (2016) 0.75

Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods (2005) 0.85

The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Res (2007) 0.85

Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain Res (2006) 0.85

A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Methods (2004) 0.82

Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. Eur J Pharmacol (2006) 0.81

Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res (2004) 0.81

Protonation effect on drug affinity. Eur J Pharmacol (2004) 0.75